Sana Biotechnology raised $655m in Series A-2/B financing.

Synopsis

Sana Biotechnology, a biotechnology company in Seattle, Washington, raised $655m in Series A-2/B financing with participation from ARCH and F-Prime.

Principals

Sana Biotechnology

Arch Capital Group

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

brian cuneo

Latham & Watkins

Lawyer

target

Deals

£ 7.05 B

Total Value

steve harr

CEO at SANA BIOTECHNOLOGY

Manager

target

Deals

£ 1.08 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy